FLUSHING FINANCIAL CORP Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision (benefit) for credit losses
Depreciation and amortization of premises and equipment
Net (gain) loss on sales of loans
Net amortization (accretion) of premiums and discounts
Net (gain) loss on sales of OREO
Net loss (gain) from disposition of assets
Amortization of premium, net of accretion of discount
Net loss on sales of OREO
Impairment of goodwill
Net loss (gain) from sale of securities
Deferred income tax provision (benefit)
Net loss (gain) from fair value adjustments
Net (gain) loss from fair value adjustments of hedges
Gain from life insurance proceeds
Income from Bank owned life insurance
Stock-based compensation expense
Deferred compensation
Amortization of core deposit intangibles
Decrease (increase) in other assets
(Decrease) increase in other liabilities
Net cash provided by (used in) operating activities

Investing Activities
Purchases of premises and equipment
Net (purchases) redemptions of Federal Home Loan Bank-NY shares
Purchases of Federal Home Loan Bank New York stock
Redemptions of Federal Home Loan Bank New York stock
Total net (purchases) redemptions of Federal Home Loan Bank-NY shares

Purchases of securities held-to-maturity
Proceeds from prepayments of securities held-to-maturity
Proceeds from calls of securities held-to-maturity
Purchases of securities available for sale
Proceeds from sales and calls of securities available for sale
Proceeds from maturities and prepayments of securities available for sale
Proceeds from sale of assets
Purchases of bank owned life insurance
Proceeds from sale of real estate owned
Proceeds from bank owned life insurance
Change in cash collateral
Net repayments (originations) of loans
Purchases of loans
Proceeds from sale of OREO, net
Proceeds from sale of loans originally classified as held for investment
Cash used in acquisition of Empire Bancorp, Inc.
Cash provided by acquisition of Empire Bancorp, Inc.
Net cash provided by (used in) investing activities

Financing Activities
Net increase (decrease) in noninterest-bearing deposits
Net increase (decrease) in interest-bearing deposits
Net increase (decrease) in mortgagors' escrow deposits
Net (repayments) proceeds from short-term borrowed funds
Proceeds from long-term borrowing
Repayment of long-term borrowings
Purchase of treasury stock
Repurchase of shares to satisfy tax obligations
Net proceeds received in common stock offering
Cash dividends paid
Net cash provided by (used in) financing activities
Net (decrease) increase in cash and cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Supplemental disclosure of cash flow information:
Cash payments for:
Interest paid
Income taxes paid, net of refunds
Taxes paid if excess tax benefits on stock-based compensation were not tax deductible

Supplemental disclosure of non- cash flow investing activities:
Transfer of loans held for investment to other real estate owned
Transfer of loans held for investment to loans held for sale
Transfer of loans held for sale to loans held for investment
Securities purchased not yet settled
Securities transferred from held to maturity to available for sale

Comments